These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35451759)

  • 1. VEGF-A
    Pellet-Many C
    Methods Mol Biol; 2022; 2475():205-214. PubMed ID: 35451759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotactic Migration of Endothelial Cells Towards VEGF-A₁₆₅.
    Pellet-Many C
    Methods Mol Biol; 2015; 1332():151-7. PubMed ID: 26285752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor is a chemoattractant for trophoblast cells.
    Lash GE; Warren AY; Underwood S; Baker PN
    Placenta; 2003 May; 24(5):549-56. PubMed ID: 12744932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of cellular chemotaxis with ECIS/Taxis.
    Pietrosimone KM; Yin X; Knecht DA; Lynes MA
    J Vis Exp; 2012 Apr; (62):. PubMed ID: 22491349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boyden chamber assay.
    Chen HC
    Methods Mol Biol; 2005; 294():15-22. PubMed ID: 15576901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro (Trans)Migration Experiment Using Chemokines as Stimulatory Factor.
    Maas SL; van der Vorst EPC
    Methods Mol Biol; 2023; 2597():77-87. PubMed ID: 36374415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-A165 potently induces human blood-nerve barrier endothelial cell proliferation, angiogenesis, and wound healing in vitro.
    Reddy CL; Yosef N; Ubogu EE
    Cell Mol Neurobiol; 2013 Aug; 33(6):789-801. PubMed ID: 23712256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells.
    Sakamoto T; Ishibashi T; Kimura H; Yoshikawa H; Spee C; Harris MS; Hinton DR; Ryan SJ
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1076-83. PubMed ID: 7537258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choroidal endothelial cells transmigrate across the retinal pigment epithelium but do not proliferate in response to soluble vascular endothelial growth factor.
    Geisen P; McColm JR; Hartnett ME
    Exp Eye Res; 2006 Apr; 82(4):608-19. PubMed ID: 16259980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking of VEGF-A is not sufficient to completely revert its long-term effects on the barrier formed by retinal endothelial cells.
    Deissler HL; Rehak M; Busch C; Wolf A
    Exp Eye Res; 2022 Mar; 216():108945. PubMed ID: 35038456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF receptor 2 inhibitor nintedanib completely reverts VEGF-A
    Deissler HL; Stutzer JN; Lang GK; Grisanti S; Lang GE; Ranjbar M
    Exp Eye Res; 2020 May; 194():108004. PubMed ID: 32184103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of the Transwell® assay for the analysis of neutrophil chemotaxis using flow cytometry to refine the clinical investigation of immunodeficient patients.
    Lauwers M; Verschelden G; Boero C; Baleine M; Kerrels V; Cantinieaux B
    Clin Immunol; 2022 May; 238():108994. PubMed ID: 35390547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rac regulates vascular endothelial growth factor stimulated motility.
    Soga N; Connolly JO; Chellaiah M; Kawamura J; Hruska KA
    Cell Commun Adhes; 2001; 8(1):1-13. PubMed ID: 11775025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining whether observed eukaryotic cell migration indicates chemotactic responsiveness or random chemokinetic motion.
    Szatmary AC; Nossal R
    J Theor Biol; 2017 Jul; 425():103-112. PubMed ID: 28501636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transwell In Vitro Cell Migration and Invasion Assays.
    Justus CR; Marie MA; Sanderlin EJ; Yang LV
    Methods Mol Biol; 2023; 2644():349-359. PubMed ID: 37142933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
    Anand-Apte B; Pepper MS; Voest E; Montesano R; Olsen B; Murphy G; Apte SS; Zetter B
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):817-23. PubMed ID: 9112976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cell migration in stable gradients of vascular endothelial growth factor A and fibroblast growth factor 2: effects on chemotaxis and chemokinesis.
    Barkefors I; Le Jan S; Jakobsson L; Hejll E; Carlson G; Johansson H; Jarvius J; Park JW; Li Jeon N; Kreuger J
    J Biol Chem; 2008 May; 283(20):13905-12. PubMed ID: 18347025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of VEGF-A-stimulated lamellipodial extensions and motility of vascular endothelial cells by chondromodulin-I, a cartilage-derived angiogenesis inhibitor.
    Miura S; Mitsui K; Heishi T; Shukunami C; Sekiguchi K; Kondo J; Sato Y; Hiraki Y
    Exp Cell Res; 2010 Mar; 316(5):775-88. PubMed ID: 20026108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals.
    Waltenberger J; Lange J; Kranz A
    Circulation; 2000 Jul; 102(2):185-90. PubMed ID: 10889129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor A (VEGF-A) decreases expression and secretion of pleiotrophin in a VEGF receptor-independent manner.
    Poimenidi E; Theodoropoulou C; Koutsioumpa M; Skondra L; Droggiti E; van den Broek M; Koolwijk P; Papadimitriou E
    Vascul Pharmacol; 2016 May; 80():11-9. PubMed ID: 26924457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.